Last reviewed · How we verify

NCT04146246

Comparative Evaluation of the FINDER Instrument and FINDER G6PD Cartridge in Adults and Neonates

Completed Last updated 23 November 2020
What this trial tests

trial testing G6PD assay in G6PD in 119 participants. Completed in 13 March 2020.

Timeline
11 November 2019
Primary endpoint
13 March 2020
13 March 2020

Quick facts

Lead sponsorBaebies, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment119
Start date11 November 2019
Primary completion13 March 2020
Estimated completion13 March 2020
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Baebies, Inc.

Who can join

Adults 35 Weeks to 100, any sex, with G6PD or G6PD Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective clinical study to compare the clinical performance of the FINDER™ Instrument and the G6PD assay to an FDA cleared instrument/reagent combination in adult and neonate populations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Baebies, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04146246.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing